William Graber

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

27

H-Index

1

About

William Graber is a prominent urologic oncologist whose research centers on optimizing quality of life outcomes for men with prostate cancer. His major contribution lies in providing crucial comparative data on patient-reported outcomes following different treatment modalities. Graber’s most cited work, a 2017 prospective cohort study, directly compared quality of life after brachytherapy versus bilateral nerve-sparing robot-assisted radical prostatectomy. This landmark paper, with 27 citations, offers evidence-based insights that help patients and clinicians navigate the difficult decision between these two common treatments. By focusing on functional recovery and patient well-being rather than oncologic outcomes alone, Graber’s research empowers men to make informed choices aligned with their personal priorities. His work is notable for its rigorous prospective design and patient-centered approach, bridging the gap between surgical expertise and the lived experience of cancer survivors. Graber’s findings continue to influence clinical counseling and shared decision-making in prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort
27 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago